Bharat Biotech asked to provide more data on Covaxin for below 12-year-olds

This development comes after the Subject Expert Committee discussed recommendations for the restricted emergency of Covaxin in children aged between 2-12 years

New Delhi [India], April 22 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said.

This development comes after the Subject Expert Committee discussed recommendations for...read more

Comments

Popular posts from this blog

Give govt time to restore normalcy in J&K as situation 'very sensitive': SC

MGNREGS can be used to gauge rural distress at grassroots level: Eco Survey

No protection to PSU employees from criminal persecution, rules SC